<prompt> DMHTNObesity-Drug Of ChoiceGlibenclamideMetforminVildagliptinEmpagliflozin  <response>: Gliflozins are SGLT2 inhibitors which cause loss of glucose,sodium and water from the body leading to reduction in BP,Glucose and weight.But they increase the risk of UTI. Ref; Katzung 12th ed. 